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Background Increased concentrations of particles in air have been related to changes in
inflammatory markers that in turn are hypothesized in mediating the particle
effects on cardiovascular disease. The present work examined this association in
an elderly cohort in the Greater Boston area and addresses the relative role of
particles from different sources.
Methods The study included 710 subjects, active members of the VA Normative Aging
Study cohort with measurements of blood markers. Concentrations of particle
number (PN), black carbon (BC), fine particulate matter (PM2.5), and sulphates
were measured at a central site near the examination site.
Results Positive associations were found between traffic-related particles (PN and BC)
and inflammatory markers, but only suggestive associations were found with
exposures to PM2.5 and sulphates. The particle effect on the inflammatory
markers was greater among subjects older than 78 years and among obese. A
suggestion for a greater effect of particles on inflammatory markers among
GSTM1-null subjects and non-users of statin drugs was also seen.
Conclusions The findings of the study support the hypothesis that particles can induce
cardiovascular disease through inflammatory pathways, suggestive of a greater
toxicity of traffic-related particles.
Keywords Air pollution, C-reactive protein, blood sedimentation, fibrinogen, inflammation,
sulphates, white blood cells
The consistent evidence for the positive association between
airborne particles, morbidity and mortality has led several
investigators to explore the underlying mechanisms that lead to
exposure-related responses. It has been hypothesized that
particles in air induce inflammation, which in turn could lead
to cardiovascular effects.
1–7
High concentration of particles in
air have been associated with increased blood clotting factors
such as serum levels of fibrinogen,
1,8–11
inflammatory factors
such as C-reactive protein,
6,12,13
increased plaque formation
and decreased plaque stability,
14
vasoconstriction, impaired




all suggested as potential mechanisms leading
to cardiovascular morbidity.
Attention has also recently focused on the relative toxicity of
particles from different sources and the potential that different
biological pathways are influenced by different types of
particles. In particular some studies have suggested greater
effects of particles from traffic sources than from coal burning
power plants (sulphates) on some cardiovascular endpoints
such as heart rate variability,
18
while for others, such as flow
mediated dilation, sulphates have been equipotent.
17
Identi-
fying relative toxicity from different sources of particles is
particularly important in allowing the best targeting of control
strategies to improve public health.
Given this evidence, the present study was carried out with
the hypothesis that increases in particle concentrations are
related to changes in inflammatory markers, such as white
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blood cell (WBC) count, C-reactive protein levels and sediment
rate, and thrombotic factors such as serum levels of fibrinogen,
that may be potential risk factors for cardiovascular disease.
The study also aimed to evaluate the relative toxicity of
sulphate particles vs particles from traffic on these intermediary
markers of cardiovascular disease.
Methods
Study population
The present work included subjects from an ongoing study of
aging established by the Veterans Administration in 1963,
enrolling 2280 community-dwelling men from the Greater
Boston area (ages 21–80 years), who were confirmed to be free
of known chronic medical conditions (The Normative Aging
Study—NAS).
19
Participants in the study are examined every
3 years. For the present work we included 710 currently active
subjects who were examined between November 14, 2000 and
December 31, 2004.
The examination of the study subjects took place in the
study centre, in the morning, after an overnight fast and
abstinence from smoking. Blood drawings were taken at that
time by a technician. Later in the morning, following the
clinical examination, the subjects’ height and weight were also
measured. On the same day, subjects were asked to respond to a
questionnaire concerning cigarette smoking, alcohol consump-
tion, medical conditions, and medication use. The responses
to this questionnaire were then confirmed by a physician
interview. Temperature of the room where the examination
was performed was kept within 24–25C.
Markers of inflammation
The markers of inflammation/thrombosis obtained for this
study were WBC count, C-reactive protein, sediment rate, and
fibrinogen. The WBC count was performed using a standard
automated electrical impedance hematology analyzer (Coulter
Counter Model S-Plus Series—Coulter Electronics). C-reactive
protein concentrations were determined using an immuno-
turbidimetric assay on the Hitachi 917 analyzer (Roche
Diagnostics—Indianapolis, IN), using reagents and calibrators
from Denka Seiken (Niigata, Japan).
20
Sediment rate was
measured with the Wintrobe Method, which is performed in a
100 mm tube (Wintrobe tube) containing oxalate as the
anticoagulant.
21




A key aim of this study was to examine the effects of particles
from different sources. We used continuous measurements of
concentrations of particle number (PN), black carbon (BC), and
particulate matter of aerodiameter <2.5 mm (PM2.5), and 24 h
integrated measurements of particulate sulphate (SO24 ), all
measured at the Harvard School of Public Health monitoring
sites: on the roof of the School of Public Health Building 2
(677 Huntington Avenue, Boston, MA), and Countway Library
(10 Shattuck Street, Boston, MA), ~1 km away from the
examination site. Because the two sites are within 30 m of
each other, we combined the data received from either one.
There was no period when we had data from both sites
simultaneously.
PN (particle count) was measured using a TSI Condensation
Particle Counter (CPC) Model 3022a, and is a measure of the
number of particles (0.007–3 mm) detected per cubic centi-
metre. BC measurements were carried out using a Magee
Scientific Aethalometer (AE-16). Concentration of BC was
expressed as ng/m
3
. Measurements were taken every 5 min,
and then averaged to 30 min concentrations. All BC concen-
trations ,400 ng/m
3
and .10 000 ng/m
3
were excluded
from the original exposure data. PM2.5 was measured using a
Tapered Element Oscillating Microbalance (TEOM), Rupprecht
& Pataschnick 1400A model, operated at 50C with two
4LPM-PM2.5 impactors before the inlet. Measurements were
recorded in 30 min averages and expressed in mg/m3. Because
TOEM monitors can lose semi-volatile particles owing to
heating of the sample filter to 50C, a season-specific calibra-
tion factor was applied to compensate for this loss.
23
Particulate
sulphate (SO24 ) was measured using the Harvard/EPA Denuder
System (HEADS), which samples inorganic gaseous and
particulate species in air. Concentrations of SO24 were
calculated from the net sulphate ion concentration on the
Teflon filter and the net volume of ambient air sampled.
Samples were collected for 24 h periods (9 a.m. to 9 a.m.), and
the date given was the starting date of the sample. Concen-
trations of SO24 were expressed in mg/m
3
.
Depending on the mechanism, the effects of airborne
particles may take time to develop, and many studies have





as relevant to cardiovascular mortality. An
animal study in Boston, using chemiluminescence, showed that
following transfer of animals from Boston air to filtered air,
reactive oxygen species in the heart, lung, and liver declined
continuously for 5 days (end of experiment).
26
This suggests
long averaging times may be appropriate. The MONICA study
6
showed the association between particles and C-reactive
protein with a 6 day average. Therefore, one would also
expect to see similar associations between longer-term average
exposures and these intermediary markers of disease. Con-
sequently, we calculated moving averages for each pollutant
concentration for the 48 h, 1 and 4 weeks preceding each
subject’s examination, using hourly measurements for PN,
BC, and PM2.5, and daily measurements for SO
2
4 . Lagged
exposure concentrations were matched on the hour of the
blood measurement for PN, PM2.5, and BC and on the day of
examination for SO24 .
Missing daily values of each pollutant were estimated using
non-linear regression models that included local meteorological
data obtained from the United States Surface Airways and
Airways Solar Radiation hourly data (including extinction
coefficient,
27
a measure of light scattering by fine particles).
Statistical methods and analyses
Measurements of markers of inflammation were natural
log-transformed to normalize the distribution of the outcome
and stabilize the variance. Linear regression analyses were
carried out to evaluate the relationship between inflammatory
markers and different lagged averages of air pollutants.
We controlled all analyses for important factors such as age
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(quadratic function), body mass index (BMI—calculated as
weight in kilograms/height in meters square—kg/m
2
), season
(used as an indicator variable, with winter the reference). We
controlled additionally for the effect of weather by including
in models temperature, relative humidity, and barometric
pressure. We also examined non-linear effects of age, BMI, and
season using non-parametric regression models.
We assessed potential confounding by use of anti-
hypertensive or cardiac medications; the presence of hyper-
tension defined as systolic blood pressure of >140 mm Hg,
diastolic blood pressure of >90 mm Hg, or reported use of
anti-hypertensive medication
28
; smoking (indicator variable—
current, former vs never); alcohol drinking (yes/no); and
fasting glucose levels.
We examined for effect modification of the air pollutant-
marker associations by age (dichotomized into >78 years—the
cut point for the upper quartile of age distribution among study
subjects, or ,78 years); obesity (BMI > 30 kg/m
2
); use of
anti-hypertensive and cardiac medications including anti-
arrhythmics, angiotensin-converting enzyme inhibitors, beta-
blockers, and calcium-channel blockers; whether the subject
was homozygous for the deletion of glutathione-S-transferase
M1 (GSTM1)-null statin drugs use; high blood pressure defined
as either diastolic blood pressure .82 mm Hg, or systolic blood
pressure .140 mm Hg (75th percentiles of the distribution
among study subjects); and hypertension defined as above.
We tested for statistically important differences between
effect estimates of strata of a potential effect modifier (for
example the difference between the two categories of








where, Q̂1 and Q̂2 are the estimates for the two categories of an
effect modifier and SÊ1 and SÊ2 their respective standard
errors.
29,30
Regardless of significance, we considered modifica-
tion of effect by a factor of 2 or more to be important and
discuss it as such.
Two-pollutant models were also carried out to examine the
sensitivity of the marker-pollutant associations in the presence
of other pollutants.
Results
The study included elderly subjects with a mean age of 73 years
(Table 1). Almost a quarter of the study subjects were above
the defined limit for obesity (BMI > 30 kg/m
2
). The
distribution of the inflammatory markers was skewed—hence
were log-transformed for the subsequent analyses. About 53%
of the study subjects were currently using anti-hypertensive or
cardiac medication, and 36% were users of statin drugs. GSTM1
was present in 41% of the study subjects. Current smokers
were only a small proportion in our study, while almost
two-thirds of subjects had a smoking history.
The distribution of air pollutants in our study is presented
in Table 2. Particle concentration distributions for the pollut-
ants were moderately skewed. Sufficient variability was present
for concentrations of the four pollutants among the study
subjects. No important correlations were observed between
pollutant pairs.
Changes in inflammatory markers and thrombotic risk were
measured by the change in fibrinogen, C-reactive protein,
sediment rate, and WBC count in relation to changes in
concentrations of particles (Table 3). All the results are reported
as percentage increase in the marker for 1 SD increase in
the concentration of the air pollutant.
PN concentration in the prior 48 h was associated with
increased fibrinogen levels (4.19%; 95% CI 5 2.04–6.34%),
as were concentrations the week before (2.14%; 95% CI 5
0.05–4.23%). A suggestive finding was seen for an association
with C-reactive protein levels for PN concentrations 48 h prior.
For sedimentation rate, in contrast, the only association
was with the average over the preceding 4 weeks (43.65%;
95% CI 515.47–71.83%). No effect was found for this
pollutant and WBC count.
Effects of BC concentrations on fibrinogen and sediment rate,
and a suggestive effect on C-reactive protein were consistently
seen with a 4 week moving average, while no effect was seen
for WBC count. The relative change for 1 SD change in the
concentration level to this pollutant for fibrinogen was 1.78%
(95% CI 5 0.19–3.36%). For C-reactive protein, a marginally
precise association was seen (5.41%; 95% CI 5 1.00 to
11.81%), whereas a statistically important association was seen
for sediment rate (21.65% increase; 95% CI 5 1.48–41.82%).
Table 1 The VA Normative Aging Study subjects’ characteristics
between November 2000 and December 2004
Mean SD 25th% 50th% 75th% 90th%
Age (years) 73.0 6.7 68 73 78 82
BMI (kg/m
2




) 6.4 3.2 5.2 6.0 7.1 8.4
Fibrinogen (mg/dl) 348.5 88.5 294 332 387 457
C-reactive protein
(mg/dl) 0.35 0.85 0.08 0.17 0.35 0.65
















Statin use 256 36.1
GSTM1 present 292 41.1
Smoking status
Never smoker 195 27.5
Current smoker 32 4.5
Former smoker 460 65.0
Missing information 21 3.0
a
Angiotensin converting enzyme.
INFLAMMATORY MARKERS AND AIR POLLUTION 1349
High concentrations of PM2.5 4 weeks prior showed a
suggestive positive association with fibrinogen levels (1.14%
increase; 95% CI 5 0.60 to 2.88%) and a positive association
with sediment rate (24.93% increase; 95% CI 5 0.68–49.18%).
No statistically precise associations were found between
SO24 concentrations and any of the inflammatory outcomes.
However, suggestive evidence was seen for an association with
fibrinogen (1.12%; 95% CI 5 0.52 to 2.77%) and C-reactive
protein (5.29%; 95% CI 5 1.91 to 12.49%) for concentra-
tions 4 weeks prior.
The use of non-parametric models with spline terms for age,
BMI, and season, control for weather, or the presence of other
pollutants in the model did not change the effects of exposure
on inflammatory markers. We found no confounding of the
marker–pollutant associations by use of anti-hypertensive or
cardiac medications, the presence of hypertension, smoking,
alcohol drinking (yes/no), or fasting glucose levels.
Effect modification
Although no statistically important difference was found for
any category of effect modifiers, there was suggestion that older
age (78 years or older) increased the effect of PN concentrations
on fibrinogen and C-reactive protein levels (Table 4). Almost all
the effect of BC on sediment rate was seen in the younger
group.
About a 2-fold relative effect was seen for the association of
PN with fibrinogen among the obese. A ~4-fold difference was
seen for the association between BC and C-reactive protein in
the presence of obesity. There was also a suggestion for effect
modification by obesity of the association between BC and
sediment rate.
We observed a suggestive greater effect of BC on C-reactive
protein among GSTM1-null subjects (9.73%; 95% CI 5 1.48–
17.98%) vs GSTM1-present subjects (2.97%; 95% CI 5
14.05 to 8.10%) for concentrations 4 weeks prior. A similar,




















) 35 101 10.4 27 160 15 851 24200 37 153 49 390 1.0 0.30 0.02 0.15
Black carbon (ng/m
3
) 43 320 3.0 0.77 0.63 0.61 1.00 1.51 1.0 0.52 0.30
PM2.5 (mg/m
3
) 42 391 8.1 11.16 7.95 9.39 14.57 21.48 1.0 0.50
SO4
2
(mg/m3) 1491 0 2.29 1.62 1.84 2.81 4.10 1.0
a
Total number of measurements after filling in missing values as described in text.
b







Table 3 The association between thrombotic and inflammatory markers and concentrations of particle components
Pollutant





% 95% CI % 95% CI % 95% CI
Particle number
48 h 4.19 2.04–6.34 7.29 1.63 to 16.21 21.24 6.94 to 49.42 0.84 1.64 to 3.32
1 week 2.14 0.05–4.23 2.33 10.96 to 6.30 23.45 4.13 to 51.03 1.07 3.51 to 1.37
4 weeks 0.12 2.00 to 2.24 7.16 16.31 to 1.98 43.65 15.47–71.83 0.26 2.25 to 2.78
Black Carbon
48 h 0.84 0.63 to 2.31 4.51 2.03 to 11.06 4.56 25.55 to 16.43 0.63 2.45 to 1.19
1 week 0.60 0.95 to 2.15 1.07 5.55 to 7.68 1.98 18.15 to 22.11 0.13 1.87 to 1.60
4 weeks 1.78 0.19–3.36 5.41 1.00 to 11.81 21.65 1.48–41.82 0.55 2.36 to 1.26
PM2.5
48 h 0.18 1.93 to 1.57 4.88 13.29 to 3.53 16.91 43.66 to 9.84 3.18 5.39 to 0.97
1 week 1.39 3.46 to 0.67 1.37 10.44 to 7.71 18.89 47.48 to 9.70 0.51 3.02 to 2.00
4 weeks 1.14 0.60 to 2.88 4.36 3.25 to 11.96 24.93 0.68–49.18 0.03 2.17 to 2.10
SO4
2
48 h 0.60 1.23 to 2.42 1.57 7.13 to 10.27 4.05 23.26 to 31.36 0.12 2.35 to 2.11
1 week 0.03 1.93 to 1.99 0.21 8.27 to 8.69 5.87 32.39 to 20.64 0.48 2.87 to 1.90
4 weeks 1.12 0.52 to 2.77 5.29 1.91 to 12.49 1.60 25.24 to 22.04 0.75 1.30 to 2.80
In bold are presented precisely estimated effects.
a
Estimates are presented as percentage increase in inflammatory marker per 1 SD increase in the pollutant. All models are adjusted for Age, Age
2
, BMI, and
season (spring, summer, and fall as indicator variables—reference winter).
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but weaker signal was seen for PN (data not shown). A stronger
effect of BC on sediment rate was seen among non-users of
statins (36.01%; 95% CI 5 13.88 to 58.13%) compared with
users (12.29%; 95% CI 5 39.13 to 14.55%).
Increased diastolic or systolic blood pressure, or current use
of anti-hypertensive and cardiac medication did not modify the
associations between inflammatory markers and air pollutants
(data not shown).
Discussion
The present study found effects of ambient concentrations of
traffic-source particles and suggestive findings for effects of
sulphates on intermediary markers of cardiovascular disease
when averaged over medium timescales (generally several days
to few weeks). The findings of this study extend previous
epidemiological observations by examining the role of particles
from different sources. Sulphates showed weakly suggestive
evidence for an association with increased level of fibrinogen
and C-reactive protein, and no association with sediment rate
or WBC count. Traffic particles, in contrast, were associated
with thrombotic and inflammatory markers. Such a finding
supports previous evidence that exposure to increased con-
centrations of particles is associated with observable changes in
response of inflammatory markers, which may in part explain
the observed association between air pollution and cardiovas-
cular events. None of these associations were confounded by
other factors influencing cardiovascular disease or changed for
non-linear terms of age, BMI, season, or control for weather.
We found a positive effect for PN concentrations with
fibrinogen, a thrombotic factor, a positive effect for sediment
rate, and only a suggestive association with C-reactive protein,
but not with WBC count—inflammatory markers, although the
lag structure was less consistent. BC showed similar positive
associations with a consistent lag structure. Similarly, PM2.5
showed a suggestive positive association with fibrinogen and
a positive association with sediment rate for concentrations
4 weeks prior.
The suggestive finding for an association of sulphates with
thrombotic and inflammatory potential, via their weak
correlation with fibrinogen and C-reactive protein levels,
adds to the recent evidence showing an association with
flow mediated dilation
17
and may partially suggest some
mechanistic pathway for the observed association between
cardiovascular mortality and sulphate levels.
31
However, since
the finding of our study was weak for this pollutant, caution
may be used in interpretation.
PN including the fine range particles represents freshly
generated local traffic particles. In contrast, BC can represent
both aged and fresh traffic particles, and includes transported as
well as locally generated traffic particles. For example, using
back trajectory analyses to determine the location of air masses
36 h before measurements of pollution concentrations in
Boston, we found the highest BC concentrations in Boston
occurred when the air masses had come from the New York
metropolitan area (results not shown). The finding that the
association with PN was generally with the shorter averaging
time may be related to this distinction, but may also be due to
chance. SO24 concentrations are markers for transported
particles from coal burning power plants. Supporting this,
back trajectory analyses showed higher concentrations of
sulphates with air masses coming from the south-west, the
coal burning facilities.









% 95% CI % 95% CI % 95% CI
Fibrinogen
Particle number
48 h 3.98 1.55–6.41 5.18 0.71–9.66 3.50 0.97–6.04 6.64 2.45–10.84
1 week 1.24 1.09 to 3.58 5.13 0.66–9.61 2.14 0.19 to 4.47 1.93 2.76 to 6.62
Black carbon
4 weeks 1.65 0.10 to 3.40 1.70 1.91 to 5.32 1.56 0.18 to 3.30 2.71 0.99 to 6.40
C-reactive protein
Particle number
48 h 5.45 4.99 to 15.89 10.78 6.43 to 27.99 7.88 2.96 to 18.72 6.32 9.55 to 22.20
Black Carbon
4 weeks 6.32 0.86 to 13.49 5.20 8.94 to 19.34 3.41 3.92 to 10.75 14.16 0.68–27.65
Sediment rate
Particle number
4 weeks 37.64 11.19–64.09 27.25 27.08 to 81.57 37.33 10.04–64.61 31.18 18.21 to 80.57
Black Carbon
4 weeks 24.58 5.07–44.09 0.72 35.15 to 36.60 15.50 3.36 to 34.35 30.79 10.05 to 71.64
In bold are presented differences in effects of a factor of 2 or greater.
a
Estimates are presented as percentage increase in inflammatory marker per 1 SD increase in the pollutant. All models are adjusted for Age, Age
2
, BMI, and
season (spring, summer, and fall as indicator variables—reference winter).
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Although much remains to be understood about the
mechanisms leading to cardiovascular disease and mortality
from exposure to particles, studies have shown that systemic
inflammation
6,32–34
and pro-thrombotic activity may be key
factors of the physio-pathological processes leading to such
events. Such processes can occur either through the release of
mediators—pro-inflammatory cytokines due to injury of the
pulmonary alveoli
33,35,36
or the direct activation of blood cells
due to deposition of particles in the lung, or due to the
infiltration of the smallest particles directly into the blood
stream,
37–39
where these may react with platelets and the
endothelium.
7,40,41
In addition, low-grade inflammation
caused by continuous exposure to air particles has been
hypothesized to be associated with increased blood coagulab-
ility, a risk factor for cardiovascular disease.
40,42
Increased fibrinogen levels, a thrombogenic factor, have
been linked to increased risk of cardiovascular disease, partly
through increased plasma viscosity and partly as an independ-
ent factor.
1
Toxicology and epidemiological studies have
shown the link between increased fibrinogen levels or plasma
viscosity and high concentrations of air pollutants.
1,3,9–11
Positive associations between C-reactive protein and par-
ticulate matter have been observed by epidemiological
studies.
6,40,43
A positive correlation of C-reactive protein
and coronary artery disease, which could be explained by
the atherogenic effects of chronic inflammation, is well
known.
44,45
Reports have suggested that C-reactive protein
may be an independent predictor of cardiovascular disease in
both men and women.
46
Although C-reactive protein levels in
our study were close to what is considered clinically normal
in a healthy human,
47
the association we found with ambient
particles may suggest possible cardiovascular risk at low-level
inflammation. This was also supported by the association
found with moderately elevated sediment rate among the
study subjects. A study by Peters
6
showed an association
between air pollution and C-reactive protein levels comparable
with that of our study.
The lagged structure of exposure effect on the inflammatory
and vascular markers in the present study suggests delayed
effects of particles on the endpoint outcomes—cardiovascular
disease morbidity and mortality. Lagged exposure effects on
these mediatory mechanisms were also seen in the MONICA
study (6). Further epidemiological evidence on delayed effects
of air pollution on morbidity and mortality has been limited.
The only study that looked at longer lags of exposure in
association with mortality events by Zanobetti et al.
25
found
increased cardiovascular mortality with particle exposures
occurring more than 1 month before the event.
The effects of traffic particles on the inflammatory markers
were modified by age and obesity in our study. Although the
mean age among our study subjects was 73 years, therefore
an elderly population, we were still able to see an indication
of effect modification by older age (those .78 years old). In
support of this finding, several studies have reported a
greater effect of air pollution among the elderly, possibly
explained by the greater susceptibility in these population
sub-groups.
48–53
Obesity, defined in our study as a BMI of 30 kg/m
2
or
greater, was associated with a 2- to 4-fold increased effect
of traffic-related particulate pollution on the inflammatory
markers. Obesity represents a pro-inflammatory state that may
be related to the release of pro-inflammatory cytokines from
fat cells,
54–56
higher circulating C-reactive protein,
57
or as
result of an inflammatory response to the poor ventilation and
performance of the lungs due to mechanical constriction of
the bronchial tree.
58,59
Considering these mechanisms, over-
weight may increase susceptibility to air pollution by enhan-
cing the response to inflammatory stimuli. In support of these
suggested mechanisms, higher C-reactive protein levels were
seen among obese subjects in our study (mean C-reactive
protein 5 0.42 mg/dl; SD 5 0.52 mg/dl vs mean C-reactive
protein 5 0.33 mg/dl; SD 5 0.93 mg/dl, among those with
BMI , 30 kg/m
2
). Obesity was also shown to be associated
with an increased response of heart rate variability to particles
in this cohort.
60
There was a suggestion for a greater effect of BC on the
inflammatory markers among GSTM1-null subjects and among
non-users of statin drugs. An earlier study of the same cohort
saw a similar effect of these two factors on reduced heart rate
variability from high concentrations of fine particles.
60
Reactive oxygen species (ROS) are important factors in the
pathogenesis of cardiovascular disease
61
and have been
suggested to influence the adverse effect of particles.
62
Genetic polymorphisms of glutathione-S-tranferases—key
factors in cellular defenses against ROS, have been shown
to modify the response to air pollutants.
63
Statins are a class
of drugs commonly prescribed for their lipid-lowering
properties, with substantial anti-inflammatory and antioxidant
activity.
63–65
Our findings support such evidence for
increased inflammatory responses in the absence of GSTM1
and statin use.
We recognize the limitation that in this study we were not
able to measure personal exposure to air pollutants. Exposure
to air particles was measured at a central monitoring site, thus,
introducing a potential for measurement error. Because of the
non-differential nature of such error, we would expect an
underestimation of the effects of air pollution observed in the
present study. Also, sulphate data were available for fewer days
in our study, and concentrations were not that high, limiting
our power to examine this source. However, the study showed
that increases in particle emissions from mobile sources, and to
a lesser extent sulphates, affected markers of potential
pathways that lead to cardiovascular disease. Such effects
were delayed from several days to several weeks. The greater
effects of air pollutants among the elderly and obese subjects
should lead to more attention toward susceptible population
sub-groups.
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KEY MESSAGES
 High concentrations of particles are associated with cardiovascular morbidity and mortality.
 Inflammatory markers and thrombotic factors are known as mediating the particle effect on cardiovascular
disease.
 High concentrations of particles were associated with changes in inflammatory and thrombotic markers, with
suggestion for greater toxicity of traffic-related particles.
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